ESMO Advanced Course on Biomarkers for Precision Medicine

28 - 29 Nov 2019

Zurich, Switzerland

ESMO Advanced Course on Biomarkers for Precision Medicine Square

Presentations from all ESMO Advanced Courses are open to all according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Meeting programme | Next/upcoming meetings

Learning objectives

An increasing number of therapeutics that require biomarkers testing are available for clinical use or are in advanced phase of clinical development
Different technologies can be used for biomarker testing depending on the nature of the biomarker and the availability of biological samples
The increasing use of large panels for comprehensive genomic profiling raises issues on data interpretation that require a multidisciplinary approach
Monitoring the molecular evolution of the disease might allow the identification of resistance mechanisms and the development of more effective therapeutic strategies
The identification of germline variants requires the activation of genetic counselling programs for patients and their families

This event has been supported by an unrestricted educational grant from Lilly Oncology and MSD.

Hide

There are 14 resources available

29 Nov 2019

Workshop 3 - How to develop a trial on precision medicine?

Presenter: Fabrice André

Session: Workshop sessions

Resources:

28 Nov 2019

Molecular pathology

Presenter: Paul Hofman

Session: Session 4 - Biomakers for Immune checkpoint inhibitors

Resources:

28 Nov 2019

Emerging biomakers

Presenter: Rodrigo Dienstmann

Session: Session 4 - Biomakers for Immune checkpoint inhibitors

Resources:

28 Nov 2019

Genomic based assays

Presenter: Albrecht Stenzinger

Session: Session 4 - Biomakers for Immune checkpoint inhibitors

Resources:

28 Nov 2019

The role of liquid biopsy in monitoring the response to treatment

Presenter: Nicola Normanno

Session: Session 3 - Clinical implementation of NGS

Resources:

28 Nov 2019

Organization and the role of the Molecular Tumour Board

Presenter: Rodrigo Dienstmann

Session: Session 3 - Clinical implementation of NGS

Resources:

28 Nov 2019

ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Presenter: Fabrice André

Session: Session 3 - Clinical implementation of NGS

Resources:

28 Nov 2019

Incidental findings of NGS testing

Presenter: Etienne Rouleau

Session: Session 3 - Clinical implementation of NGS

Resources:

28 Nov 2019

Session Single cell analyses: which impact in cancer research

Presenter: Fabrice André

Session: Session 2 - New technologies for precision medicine

Resources:

28 Nov 2019

Gene fusions

Presenter: Caterina Marchiò

Session: Session 2 - New technologies for precision medicine

Resources: